研究用フローサイトと理化学分析

世界のリサーチ分野のお客さまへ先端の検査装置のご案内です。

お問い合わせはこちら

sysmex

研究用フローサイトと理化学分析sysmex

CyFlow CD45 Purified

品番 AA542037
抗体名 Anti-Hu CD45 PURI,2D1
包装単位 0.1 mg
濃度 1 mg/ml
容量 0.1 ml
関連製品
(アイソタイプコントロール)
Mouse IgG1 Purified (BJ561896)
Mouse IgG1 Purified (AS224818)
反応性|交差吸着 Human レーザー
抗原 CD45, LCA, T200, B220 最大蛍光波長 -
クローン 2D1 最大励起波長 -
ホスト Mouse 標識/Format Purified
アイソタイプ IgG1 研究分野 Immunophenotyping
クローナリティ monoclonal 用途

Flow cytometry

Anti-Hu CD45 PURI,2D1

特異性

The mouse monoclonal antibody 2D1 recognizes all alternative forms of human CD45 antigen, a 180-220 kDa single chain type I transmembrane protein expressed at high level on all cells of hematopoietic origin, except from erythrocytes and platelets.

抗原情報

CD45 (LCA; leukocyte common antigen) is a receptor-type protein tyrosine phosphatase ubiquitously expressed in all nucleated hematopoietic cells, comprising approximately 10% of all surface proteins in lymphocytes. CD45 glycoprotein is crucial in lymphocyte development and antigen signaling, serving as an important regulator of Src-family kinases. CD45 protein exists as multiple isoforms as a result of alternative splicing; these isoforms differ in their extracellular domains, whereas they share identical transmembrane and cytoplasmic domains. These isoforms differ in their ability to translocate into the glycosphingolipid-enriched membrane domains and their expression depends on cell type and physiological state of the cell. Besides the role in immunoreceptor signaling, CD45 is important in promoting cell survival by modulating integrin-mediated signal transduction pathway and is also involved in DNA fragmentation during apoptosis.

利用方法

保存方法

Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.

安定性情報

Do not use after expiration date stamped on vial label.

レファレンス

• Ito A, Ishida T, Yano H, Inagaki A, Suzuki S, Sato F, Takino H, Mori F, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R: Defucosylated anti‑CCR4 monoclonal antibody exercises potent ADCC‑mediated antitumor effect in the novel tumor‑bearing humanized NOD/Shi‑scid, IL‑2Rgamma(null) mouse model. Cancer·Immunol·Immunother. 2009·Aug; 58(8):1195‑206. <·PMID:·19048251·>
• Janossy G, Jani IV, Bradley NJ, Bikoue A, Pitfield T, Glencross DK: Affordable CD4(+)‑T‑cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin·Diagn·Lab·Immunol. 2002·Sep; 9(5):1085‑94. <·PMID:·12204964·>
• Mariucci S, Rovati B, Bencardino K, Manzoni M, Danova M: Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects. Int·J·Lab·Hematol. 2010·Feb; 32(1‑1):e40‑8. <·PMID:·20088999·>
• Pfau JC, Walker E, Card GL: Monoclonal antibodies to CD45 modify LPS‑induced arachidonic acid metabolism in macrophages. Biochim·Biophys·Acta. 2000·Feb·28; 1495(3):212‑22. <·PMID:·10699460·>
• Vicetti Miguel RD, Harvey SA, LaFramboise WA, Reighard SD, Matthews DB, Cherpes TL: Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity. PLoS·One. 2013; 8(3):e58565. <·PMID:·23555586·>
• Wellhausen SR, Slone SP, Miller JJ: Clone‑specific anti‑CD45 blocking factor in patient plasma. Cytometry·B·Clin·Cytom. 2007·Sep; 72(5):423‑6. <·PMID:·17311353·>

Available Safety Data Sheets

CyFlow™ monoclonal antibodies SDS CA EN

Available Technical Data Sheets

CyFlow™ CD45 Purified (2D1) AA542037 TDS (US)